Later a three-component GLP vaccine by Ingale and coworkers (a three palmitic acid Pam3CSK4 moiety, a CD4+ and a B-cell epitope) showed induction of strong tumor-specific IgG responses [20]. Here, CD4 is linked to neoplasm.